1. Home
  2. OCCI vs COYA Comparison

OCCI vs COYA Comparison

Compare OCCI & COYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OFS Credit Company Inc.

OCCI

OFS Credit Company Inc.

HOLD

Current Price

$3.60

Market Cap

120.2M

Sector

Finance

ML Signal

HOLD

Logo Coya Therapeutics Inc.

COYA

Coya Therapeutics Inc.

HOLD

Current Price

$4.19

Market Cap

97.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OCCI
COYA
Founded
N/A
2020
Country
United States
United States
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
120.2M
97.8M
IPO Year
N/A
2022

Fundamental Metrics

Financial Performance
Metric
OCCI
COYA
Price
$3.60
$4.19
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$15.80
AVG Volume (30 Days)
288.5K
133.3K
Earning Date
12-11-2023
05-08-2026
Dividend Yield
24.32%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$7,945,753.00
Revenue This Year
N/A
N/A
Revenue Next Year
$10.19
$763.10
P/E Ratio
N/A
N/A
Revenue Growth
N/A
123.57
52 Week Low
$2.62
$3.71
52 Week High
$6.82
$7.75

Technical Indicators

Market Signals
Indicator
OCCI
COYA
Relative Strength Index (RSI) 76.51 45.92
Support Level $2.74 $4.00
Resistance Level $4.97 $5.08
Average True Range (ATR) 0.14 0.21
MACD 0.06 -0.02
Stochastic Oscillator 99.29 22.41

Price Performance

Historical Comparison
OCCI
COYA

About OCCI OFS Credit Company Inc.

OFS Credit Co Inc is a non-diversified, closed-end management investment company. Its investment objective is to generate current income, with a secondary objective to generate capital appreciation through investment in collateralized loan obligation (CLO) equity and debt securities. The company invests in floating rate credit instruments and other structured credit investments, including collateralized loan obligation (CLO) debt and subordinated (i.e., residual or equity) securities; traditional corporate credit investments, including leveraged loans and high yield bonds; opportunistic credit investments, including stressed and distressed credit situations and long/short credit investments; and other credit-related instruments.

About COYA Coya Therapeutics Inc.

Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary new therapies to enhance the function of regulatory T cells (Tregs). The company's initial development programs are focused on neurodegenerative, chronic inflammatory, autoimmune, and metabolic diseases with high unmet medical needs.

Share on Social Networks: